Skip to main content
Skip to main navigation menu
Skip to site footer
Open Menu
About
About the Journal
Privacy Statement
Open access policy
Contact
Current
Archives
Editorial Board
Procedure for consideration and publication of materials
Guides for authors
Cost of publication
Archive 2018-2006
Search
Login
Home
/
Archives
/
Vol. 42 No. 2 (2020): Experimental Oncology
Vol. 42 No. 2 (2020): Experimental Oncology
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-2
Published:
01.06.2023
Reviews
Human microbiota and effectiveness of cancer chemotherapy
Yu.V. Shvets, N.Yu. Lukianova, V.F. Chekhun
82-93
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-2.14611
Original contributions
NANOG as prognostic factor of prostate cancer course
T.V. Zadvornyi, N.Yu. Lukianova, T.V. Borikun, Yu.V. Vitruk, E.O. Stakhovsky, V.F. Chekhun
94-100
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-2.14673
Anti-proliferative effects of a blueberry extract on a panel of tumor cell lines of different origin
H. Lamdan, R.S. Garcia-Lazaro, N. Lorenzo, L.G. Caligiuri, D.F. Alonso, H.G. Farina
101-108
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-2.14766
Inhibition of USP1, a new partner of Bcr-Abl, results in decrease of Bcr-Abl level in K562 cells
S.V. Antonenko, G.D. Telegeev
109-114
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-2.14533
Expression of micro-RNA hsa-miR-30c-5p and hsa-miR-138-1 in renal cell carcinoma
K.V. Onyshchenko, T.V. Voitsitskyi, V.M. Grygorenko, N.O. Saidakova, L.V. Pereta, A.P. Onyschuk, I.Ya. Skrypkina
115-119
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-2.14632
Conjugation of new DNA vaccine with polyethylenimine induces cellular immune response and tumor regression in neuroblastoma mouse model
M.V. Stegantseva, V.A. Shinkevich, E.M. Tumar, A.N. Meleshko
120-125
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-2.14473
Peculiarities of abnormal karyotypes formation in therapy-related acute leukemias
S.V. Andreieva, O.A. Kyselova, I.M. Serbin, O.G. Alkhimova
126-129
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-2.14593
HRM screening of the UBC9 gene encoding the SUMO-E2-conjugating enzyme — case-control study in breast cancer
P. Bialik, D. Wysokinski, M. Slomka, Z. Morawiec, D. Strapagiel, K. Wozniak
130-134
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-2.14739
Clinicopathological correlation of the expression of excision repair cross complementation group 1 (ERCC1) in oral cavity squamous cell carcinomas: an immunohistochemical study
D. Pankaj, V. Guddattu, M.C. Solomon
135-139
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-2.14461
Prognostic role of androgen receptor expression in patients with metastatic triple negative breast cancer
S.A. Lyalkin, N.O. Verevkina, O.O. Alekseyenko, L.A. Syvak
140-143
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-2.14579
Expression of Ki-67 and CD34 on blood and bone marrow cells of CML patients with different response to imatinib and nilotinib therapy
T. Perekhrestenko, U. Melnyk, N. Goryainova, I. Diagil
144-147
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-2.14497
Temozolomide in glioblastoma treatment: 15-year clinical experience and analysis of its efficacy
O.Ya. Glavatskyi, O.V. Zemskova, H.V. Khmelnytskyi, K.A. Kardash, I.M. Shuba, V.A. Stuley
148-156
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-2.14503
Social aspects of oncological care
Specialized care provided to patients with rectal cancer in Kyiv city
O.M. Kliusov
157-160
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-2.14560
Language
Українська
English
Current Issue